<?xml version="1.0"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="en">
	<id>http://emdrive.echothis.com/index.php?action=history&amp;feed=atom&amp;title=Indications_Side_Effects_Warnings.</id>
	<title>Indications Side Effects Warnings. - Revision history</title>
	<link rel="self" type="application/atom+xml" href="http://emdrive.echothis.com/index.php?action=history&amp;feed=atom&amp;title=Indications_Side_Effects_Warnings."/>
	<link rel="alternate" type="text/html" href="http://emdrive.echothis.com/index.php?title=Indications_Side_Effects_Warnings.&amp;action=history"/>
	<updated>2026-09-12T05:10:53Z</updated>
	<subtitle>Revision history for this page on the wiki</subtitle>
	<generator>MediaWiki 1.41.1</generator>
	<entry>
		<id>http://emdrive.echothis.com/index.php?title=Indications_Side_Effects_Warnings.&amp;diff=211141&amp;oldid=prev</id>
		<title>SoilaX267026 at 22:42, 22 July 2024</title>
		<link rel="alternate" type="text/html" href="http://emdrive.echothis.com/index.php?title=Indications_Side_Effects_Warnings.&amp;diff=211141&amp;oldid=prev"/>
		<updated>2024-07-22T22:42:36Z</updated>

		<summary type="html">&lt;p&gt;&lt;/p&gt;
&lt;table style=&quot;background-color: #fff; color: #202122;&quot; data-mw=&quot;interface&quot;&gt;
				&lt;col class=&quot;diff-marker&quot; /&gt;
				&lt;col class=&quot;diff-content&quot; /&gt;
				&lt;col class=&quot;diff-marker&quot; /&gt;
				&lt;col class=&quot;diff-content&quot; /&gt;
				&lt;tr class=&quot;diff-title&quot; lang=&quot;en&quot;&gt;
				&lt;td colspan=&quot;2&quot; style=&quot;background-color: #fff; color: #202122; text-align: center;&quot;&gt;← Older revision&lt;/td&gt;
				&lt;td colspan=&quot;2&quot; style=&quot;background-color: #fff; color: #202122; text-align: center;&quot;&gt;Revision as of 15:42, 22 July 2024&lt;/td&gt;
				&lt;/tr&gt;&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot; id=&quot;mw-diff-left-l1&quot;&gt;Line 1:&lt;/td&gt;
&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot;&gt;Line 1:&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;−&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;&lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;Tell &lt;/del&gt;your &lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;doctor right now if you &lt;/del&gt;(or your &lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;youngster&lt;/del&gt;)&lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;: could not be viewing as well as before starting SABRIL; begin to trip&lt;/del&gt;, &lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;run into points&lt;/del&gt;, &lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;or are extra awkward than typical &lt;/del&gt;[https://&lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;www.protopage&lt;/del&gt;.com/&lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;galairyvym Bookmarks&lt;/del&gt;]&lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;; are surprised by things &lt;/del&gt;or &lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;people can be found in front &lt;/del&gt;of &lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;you that seem &lt;/del&gt;to &lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;find out &lt;/del&gt;of &lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;no place; &lt;/del&gt;or &lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;if your infant is acting differently than regular&lt;/del&gt;.&amp;lt;br&amp;gt;&amp;lt;br&amp;gt;SABRIL (vigabatrin) is a prescription medication made use of with other &lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;therapies &lt;/del&gt;in &lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;children &lt;/del&gt;and &lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;adults &lt;/del&gt;2 years old and older with refractory &lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;facility &lt;/del&gt;partial seizures (CPS) that have not &lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;reacted well enough &lt;/del&gt;to &lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;a number of &lt;/del&gt;other &lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;therapies &lt;/del&gt;and if the possible &lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;benefits &lt;/del&gt;surpass the risk of vision loss. &amp;lt;br&amp;gt;&amp;lt;br&amp;gt;&lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;One of the &lt;/del&gt;most usual &lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;negative effects &lt;/del&gt;of SABRIL in &lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;youngsters &lt;/del&gt;3 to 16 years is weight gain. With &lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;extreme &lt;/del&gt;vision loss, you &lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;might &lt;/del&gt;only have the ability to see &lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;things &lt;/del&gt;directly in front of you (&lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;often &lt;/del&gt;called one-track mind&quot;). You &lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;are at threat &lt;/del&gt;for vision loss with any &lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;amount &lt;/del&gt;of SABRIL.&amp;lt;br&amp;gt;&amp;lt;br&amp;gt;&lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;Tell your healthcare provider if &lt;/del&gt;you are expecting or intend to &lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;get pregnant&lt;/del&gt;. If vision testing can not be done, your &lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;healthcare provider &lt;/del&gt;might proceed prescribing SABRIL, however will not have the ability to &lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;expect &lt;/del&gt;any vision loss. &lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;If vision examinations are refrained on a regular basis, your healthcare &lt;/del&gt;provider might &lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;stop suggesting &lt;/del&gt;SABRIL for you (or your youngster).&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;+&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;&lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;Prior to beginning SABRIL, inform your medical professional about all of &lt;/ins&gt;your (or your &lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;kid's&lt;/ins&gt;) &lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;medical problems including anxiety&lt;/ins&gt;, &lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;state of mind problems&lt;/ins&gt;, &lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;suicidal ideas &lt;/ins&gt;[https://&lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;atavi&lt;/ins&gt;.com/&lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;share/wr6c7hz9etrq vigabatrin rems survey&lt;/ins&gt;] or &lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;behavior, any kind &lt;/ins&gt;of &lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;allergic reaction &lt;/ins&gt;to &lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;SABRIL, vision issues, kidney troubles, reduced red cell matters (anemia), and any kind &lt;/ins&gt;of &lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;mental &lt;/ins&gt;or &lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;nervous illness&lt;/ins&gt;.&amp;lt;br&amp;gt;&amp;lt;br&amp;gt;SABRIL (vigabatrin) is a prescription medication made use of with &lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;various &lt;/ins&gt;other &lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;treatments &lt;/ins&gt;in &lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;grownups &lt;/ins&gt;and &lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;youngsters &lt;/ins&gt;2 years old and older with refractory &lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;complicated &lt;/ins&gt;partial seizures (CPS) that have &lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;actually &lt;/ins&gt;not &lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;responded all right &lt;/ins&gt;to &lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;numerous various &lt;/ins&gt;other &lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;treatments &lt;/ins&gt;and if the possible &lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;advantages &lt;/ins&gt;surpass the risk of vision loss. &amp;lt;br&amp;gt;&amp;lt;br&amp;gt;&lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;The &lt;/ins&gt;most usual &lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;side effect &lt;/ins&gt;of SABRIL in &lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;kids &lt;/ins&gt;3 to 16 years is weight gain. With &lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;serious &lt;/ins&gt;vision loss, you &lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;may &lt;/ins&gt;only have the ability to see &lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;points &lt;/ins&gt;directly in front of you (&lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;in some cases &lt;/ins&gt;called one-track mind&quot;). You &lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;go to danger &lt;/ins&gt;for vision loss with any &lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;quantity &lt;/ins&gt;of SABRIL.&amp;lt;br&amp;gt;&amp;lt;br&amp;gt;&lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;If &lt;/ins&gt;you are expecting or intend to &lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;obtain expectant, inform your medical care provider&lt;/ins&gt;. If vision testing can not be done, your &lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;doctor &lt;/ins&gt;might proceed prescribing SABRIL, however will not have the ability to &lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;look for &lt;/ins&gt;any &lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;type of &lt;/ins&gt;vision loss. &lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;Your health care service &lt;/ins&gt;provider might &lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;quit recommending &lt;/ins&gt;SABRIL for you (or your youngster)&lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;if vision examinations are not done routinely&lt;/ins&gt;.&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;</summary>
		<author><name>SoilaX267026</name></author>
	</entry>
	<entry>
		<id>http://emdrive.echothis.com/index.php?title=Indications_Side_Effects_Warnings.&amp;diff=195492&amp;oldid=prev</id>
		<title>BobSaucedo26: Created page with &quot;Tell your doctor right now if you (or your youngster): could not be viewing as well as before starting SABRIL; begin to trip, run into points, or are extra awkward than typical [https://www.protopage.com/galairyvym Bookmarks]; are surprised by things or people can be found in front of you that seem to find out of no place; or if your infant is acting differently than regular.&lt;br&gt;&lt;br&gt;SABRIL (vigabatrin) is a prescription medication made use of with other therapies in chil...&quot;</title>
		<link rel="alternate" type="text/html" href="http://emdrive.echothis.com/index.php?title=Indications_Side_Effects_Warnings.&amp;diff=195492&amp;oldid=prev"/>
		<updated>2024-07-20T03:46:35Z</updated>

		<summary type="html">&lt;p&gt;Created page with &amp;quot;Tell your doctor right now if you (or your youngster): could not be viewing as well as before starting SABRIL; begin to trip, run into points, or are extra awkward than typical [https://www.protopage.com/galairyvym Bookmarks]; are surprised by things or people can be found in front of you that seem to find out of no place; or if your infant is acting differently than regular.&amp;lt;br&amp;gt;&amp;lt;br&amp;gt;SABRIL (vigabatrin) is a prescription medication made use of with other therapies in chil...&amp;quot;&lt;/p&gt;
&lt;p&gt;&lt;b&gt;New page&lt;/b&gt;&lt;/p&gt;&lt;div&gt;Tell your doctor right now if you (or your youngster): could not be viewing as well as before starting SABRIL; begin to trip, run into points, or are extra awkward than typical [https://www.protopage.com/galairyvym Bookmarks]; are surprised by things or people can be found in front of you that seem to find out of no place; or if your infant is acting differently than regular.&amp;lt;br&amp;gt;&amp;lt;br&amp;gt;SABRIL (vigabatrin) is a prescription medication made use of with other therapies in children and adults 2 years old and older with refractory facility partial seizures (CPS) that have not reacted well enough to a number of other therapies and if the possible benefits surpass the risk of vision loss. &amp;lt;br&amp;gt;&amp;lt;br&amp;gt;One of the most usual negative effects of SABRIL in youngsters 3 to 16 years is weight gain. With extreme vision loss, you might only have the ability to see things directly in front of you (often called one-track mind&amp;quot;). You are at threat for vision loss with any amount of SABRIL.&amp;lt;br&amp;gt;&amp;lt;br&amp;gt;Tell your healthcare provider if you are expecting or intend to get pregnant. If vision testing can not be done, your healthcare provider might proceed prescribing SABRIL, however will not have the ability to expect any vision loss. If vision examinations are refrained on a regular basis, your healthcare provider might stop suggesting SABRIL for you (or your youngster).&lt;/div&gt;</summary>
		<author><name>BobSaucedo26</name></author>
	</entry>
</feed>